Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Jack

Showing results (281-290 of 287) with videos related to

Pageof 29
Sort By:
You have reached the last page of results.This site can display upto 287 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 30, 2017
Central nervous system relapse of diffuse large B-cell lymphoma in the rituximab era: results of the UK NCRI R-CHOP-14 versus 21 trialM Gleeson, N Counsell, D Cunningham, et al.
American Journal of Physiology. Endocrinology and Metabolism|May 16, 2019
Phosphorylation status of fetuin-A is critical for inhibition of insulin action and is correlated with obesity and insulin resistanceGuang Ren, Teayoun Kim, James B Papizan, et al.
Frontiers in Neuroscience|June 10, 2022
The Impact of Probiotic Supplementation on Cognitive, Pathological and Metabolic Markers in a Transgenic Mouse Model of Alzheimer's DiseaseThomas S Webberley, Giulia Masetti, Ryan J Bevan, et al.
Scientific Reports|March 8, 2020
A randomised controlled study shows supplementation of overweight and obese adults with lactobacilli and bifidobacteria reduces bodyweight and improves well-beingD R Michael, A A Jack, G Masetti, et al.
The Journal of Clinical Endocrinology and Metabolism|February 1, 2021
Postconvalescent SARS-CoV-2 IgG and Neutralizing Antibodies are Elevated in Individuals with Poor Metabolic HealthSabrina E Racine-Brzostek, He S Yang, Gwendolyne A Jack, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 12, 2017
Outcome of elderly patients with diffuse large B-cell lymphoma treated with R-CHOP: results from the UK NCRI R-CHOP14v21 trial with combined analysis of molecular characteristics with the DSHNHL RICOVER-60 trialA Kühnl, D Cunningham, N Counsell, et al.
Leukemia|July 3, 2010
Anti-CD22-MCC-DM1: an antibody-drug conjugate with a stable linker for the treatment of non-Hodgkin's lymphomaA G Polson, M Williams, A M Gray, et al.
Pageof 29

Showing results (281-290 of 287) with videos related to

Sort By:
Pageof 29
You have reached the last page of results.This site can display upto 287 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 30, 2017
Central nervous system relapse of diffuse large B-cell lymphoma in the rituximab era: results of the UK NCRI R-CHOP-14 versus 21 trialM Gleeson, N Counsell, D Cunningham, et al.
American Journal of Physiology. Endocrinology and Metabolism|May 16, 2019
Phosphorylation status of fetuin-A is critical for inhibition of insulin action and is correlated with obesity and insulin resistanceGuang Ren, Teayoun Kim, James B Papizan, et al.
Frontiers in Neuroscience|June 10, 2022
The Impact of Probiotic Supplementation on Cognitive, Pathological and Metabolic Markers in a Transgenic Mouse Model of Alzheimer's DiseaseThomas S Webberley, Giulia Masetti, Ryan J Bevan, et al.
Scientific Reports|March 8, 2020
A randomised controlled study shows supplementation of overweight and obese adults with lactobacilli and bifidobacteria reduces bodyweight and improves well-beingD R Michael, A A Jack, G Masetti, et al.
The Journal of Clinical Endocrinology and Metabolism|February 1, 2021
Postconvalescent SARS-CoV-2 IgG and Neutralizing Antibodies are Elevated in Individuals with Poor Metabolic HealthSabrina E Racine-Brzostek, He S Yang, Gwendolyne A Jack, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 12, 2017
Outcome of elderly patients with diffuse large B-cell lymphoma treated with R-CHOP: results from the UK NCRI R-CHOP14v21 trial with combined analysis of molecular characteristics with the DSHNHL RICOVER-60 trialA Kühnl, D Cunningham, N Counsell, et al.
Leukemia|July 3, 2010
Anti-CD22-MCC-DM1: an antibody-drug conjugate with a stable linker for the treatment of non-Hodgkin's lymphomaA G Polson, M Williams, A M Gray, et al.
Pageof 29